Resumo Este artigo tem por objetivo discutir a expansão do agronegócio no estado de Goiás, Brasil, o uso de agrotóxicos e o adoecimento da população nos anos 2000 a 2013, com ênfase em cinco municípios localizados na Microrregião de Ceres (Goianésia, Itapaci, Uruana, Rialma e Barro Alto). O procedimento metodológico consistiu em pesquisa bibliográfica, análise exploratória de dados e análise descritiva e estatística não paramétrica. Os resultados demonstram que nos anos 2000 a 2013 o estado de Goiás e os municípios investigados tiveram crescimento da área urbana; redução do bioma Cerrado e aumento da produtividade agrícola da cana-de-açúcar, milho e soja, acompanhados, conforme dados registrados em sistemas de informação em saúde, do aumento de casos de intoxicação, tentativas de suicídios com uso de agrotóxico, neoplasias e malformações congênitas.

Abstract This article discusses the expansion of agribusiness in the state of Goiás, Brazil, the use of toxic agrochemicals or pesticides, and the resulting ailments contracted by the local population between 2000 and 2013, with emphasis on five municipalities located in the microregion of Ceres (Goianesia, Itapaci, Uruana, Rialma and Barro Alto). The approach employed in this study consisted of bibliographical research, an exploratory analysis of the data, and a non-parametric descriptive and statistical analysis. The findings reveal marked urban expansion in the aforementioned municipalities in the state of Goiás from 2000 to 2013, a shrinking Cerrado biome, and augmented agricultural productivity of sugarcane, corn and soy, accompanied by an increase in the number of poisoning victims, suicide attempts using pesticides, neoplasms and congenital malformations, according to data recorded in public health information systems.

Lagochilascariosis, a disease caused by Lagochilascaris minor, affects the neck, sinuses, tonsils, lungs, the sacral region, dental alveoli, eyeballs and the central nervous system of humans. A cycle of autoinfection may occur in human host tissues characterized by the presence of eggs, larvae and adult worms. This peculiarity of the cycle hinders therapy, since there are no drugs that exhibit ovicidal, larvicidal and vermicidal activity. Given these facts, we studied the action of levamisole hydrochloride on third-stage larvae in the migration phase (G1) and on encysted larvae (G3) of L. minor. To this end, 87 inbred mice of the C57BL/6 strain were divided into test groups comprising 67 animals (G1-37; G3-30) and a control group (G2-10; G4-10) with 20 animals. Each animal was inoculated orally with 2,000 infective eggs of the parasite. The animals of the test groups were treated individually with a single oral dose of levamisole hydrochloride at a concentration of 0.075 mg. The drug was administered either 30 minutes prior to the parasite inoculation (G1 animals) or 120 days after the inoculation (G3 animals). The mice in the control groups were not treated with the drug. After the time required for the migration and the encysting of L. minor larvae, all the animals were euthanized and their tissues examined. The data were analyzed using the Student's unpaired t-test and the Levene test. The groups showed no statistically significant difference. Levamisole hydrochloride was ineffective on third-stage larvae of L. minor. These findings explain the massive expulsion of live adult worms, as well as the use of long treatment schemes, owing to the persistence of larvae and eggs in human parasitic lesions.

INTRODUÇÃO: A lagochilascariose é uma a zoonose emergente determinada pela presença do helminto Lagochilascaris minor em tecidos humanos. A infecção ocorre por meio da ingestão de larvas encistadas no tecido subcutâneo, na musculatura e vísceras de animais silvestres consumidos pelo homem de forma crua ou mal cozidos. A doença é rara, insidiosa, de caráter crônico, caracterizada pelo surgimento de lesões, principalmente na região do pescoço, mastoide, ouvido, rino e orofaringe. A gravidade, por vezes fatal, dependerá da localização do parasito. OBJETIVO: Descrever um caso de otomastoidite por L. minor em criança, atendida no Hospital das Clínicas da Universidade Federal de Goiás. RELATO DO CASO: Paciente 10 anos, sexo feminino, com queixa de otalgia intensa e otorreia purulenta à direita. À otoscopia, a orelha esquerda apresentava-se normal, enquanto na orelha direita havia edema retroauricular, pólipo no conduto auditivo externo e fístula com drenagem de secreção purulenta. A membrana timpânica estava íntegra. As etapas do atendimento foram descritas desde a consulta inicial até a recuperação da paciente. COMENTÁRIOS FINAIS: O clínico deve estar alerta para importância em se considerar o diagnóstico diferencial de tal afecção diante de indivíduos residentes em zonas rurais.

INTRODUCTION: The lagochilascariosis is an emerging zoonosis determined by the presence of helminth Lagochilascaris minor in human tissues. Infection occurs through ingestion of larvae encysted in the subcutaneous tissue, muscles and viscera of wild animals consumed by man so raw or undercooked. The disease is rare, insidious, chronic condition, characterized by the appearance of lesions, especially in the neck, mastoid, ear, nose and oropharynx. A serious, sometimes fatal, depend on the location of the parasite. OBJECTIVE: To describe a case of otomastoiditis by L. minor in child, attended at the Hospital das Clinicas, Federal University of Goias. CASE REPORT: Patient 10 years old female, complaining of otalgia and purulent otorrhea right. Otoscopy left ear was normal, while the right ear had retroauricular edema, polyps in the external ear canal and fistula with drainage of pus. The tympanic membrane was intact.The stages of treatment were described since the initial consultation to the recovery of the patient. FINAL COMMENTS: The clinician should be alert to the importance in considering the differential diagnosis of this disease on individuals residing in rural areas.

The goal of this study was to investigate the pattern of inflammatory response induced by Lagochilascaris minor in murine experimental model. For this purpose 115 mice were given 1000-3000 L. minor infective eggs "per os" and 51 uninfected mice were considered as controls. Four hours post-inoculation (PI), 3rd stage larvae were seen passing through the mucosa of terminal ends of small intestine. Six hours PI larvae were observed as an embolus inside the portal vein and also migrating through the liver parenchyma. During the first 24 h larvae-containing eggs of L. minor were observed in the lumen of intestinal tract. Two days PI larvae were seen migrating through lung parenchyma associated with an initial neutrophilic perivasculitis. From the 13th day of this experimental study, L. minor larvae were found mainly in skeletal muscles, in the center of granulomas. Concentric fibrosis with mixed inflammatory infiltrate involved the larvae after the 47th day PI, persistently. This experimental murine study with L. minor indicated that the 3rd stage larvae penetrated via ileum-cecal mucosa reaching the liver and probably other tissues through the hematogenic via. Throughout its pathway the larvae induced a granulomatous reaction, with abundant polimorphonuclear cells.

Extrato contendo larvas de Strongyloides ratti foi usado na padronização de um ELISA para detecção de IgE gênero-específica na estrongiloidíase humana. Foram analisadas 40 amostras de soro de pacientes monoinfectados que estavam eliminando larvas de S. stercoralis nas fezes (Grupo I), 40 de pacientes com outros parasitos intestinais (Grupo II), e 40 indivíduos copronegativos (Grupo III). Níveis de IgE gênero-específica (índice ELISA: EI) foram significativamente maiores no Grupo I (EI = 1,43) do que no II (EI = 0,70) e III (EI = 0,71), mostrando positividade de 55%, 2,5% e 0%, respectivamente. Similarmente, soros dos pacientes copropositivos (Grupo I) apresentaram níveis significativamente maiores de IgE total (866 IU/mL) quando comparados com os soros dos Grupo II (302 IU/mL) e III (143 IU/mL). Uma significativa correlação positiva foi encontrada entre os níveis de IgE específica a Strongyloides sp. e IgE total nos soros de pacientes com estrongiloidíase. Em conclusão, extrato heterólogo de S. ratti mostrou ser uma ferramenta útil para detecção de IgE gênero-específica por ELISA, desta forma contribuindo para melhor caracterização do perfil da resposta imune na estrongiloidíase humana.

Strongyloides ratti larval extract was used for the standardization of ELISA to detect genus-specific IgE in human strongyloidiasis. Forty serum samples from monoinfected patients shedding S. stercoralis larvae (Group I), 40 from patients with other intestinal parasites (Group II), and 40 from copronegative healthy subjects (Group III) were analyzed. Genus-specific IgE levels (ELISA Index: EI) were significantly higher in the group I (EI = 1.43) than groups II (EI = 0.70) and III (EI = 0.71), showing positivity rates of 55%, 2.5% and 0%, respectively. Similarly, sera from copropositive patients had significantly higher levels of total IgE (866 IU/mL) as compared to those from group II (302 IU/mL) and III (143 IU/mL). A significant positive correlation was found between levels of Strongyloides specific-IgE and total IgE in sera from patients with strongyloidiasis. In conclusion, S. ratti heterologous extract showed to be a useful tool for detecting genus-specific IgE by ELISA, contributing for a better characterization of the immune response profile in human strongyloidiasis.

The present study was conducted to evaluate the frequency of antigenic components recognized by serum IgG antibodies in Western blotting (WB) using a Strongyloides ratti larval extract for the diagnosis of human strongyloidiasis. In addition, the WB results were compared to the enzyme-linked immunosorbent assay (ELISA) and the indirect immunofluorescence antibody test (IFAT) results. Serum samples of 180 individuals were analyzed (80 with strongyloidiasis, 60 with other intestinal parasitoses, and 40 healthy individuals). S. ratti was obtained from fecal culture of experimentally infected Rattus rattus. For IFAT, S. ratti larvae were used as antigen and S. ratti larval antigenic extracts were employed in WB and ELISA. Eleven S. ratti antigenic components were predominantly recognized by IgG antibodies in sera of patients with strongyloidiasis. There was a positive concordance for the three tests in 87.5% of the cases of strongyloidiasis. The negative concordance in the three tests was 94% and 97.5%, in patients with other intestinal parasitoses and healthy individuals, respectively. In cases of positive ELISA and negative IFAT results, diagnosis could be confirmed by WB. ELISA, IFAT, and WB using S. ratti antigens showed a high rate of sensitivity and specificity. In conclusion, WB using S. ratti larval extract was able to recognize 11 immunodominant antigenic components, showing to be a useful tool to define the diagnosis in cases of equivocal serology.

Relata-se um caso de parasitismo por Rhabditis sp em criança com cinco meses de idade procedente do Estado de Goiás, Brasil. O quadro clínico mostrou inicialmente diarréia com fezes líquidas esverdeadas e posteriormente sanguinolentas. O exame parasitológico de fezes revelou a presença de larvas e adultos de Rhabditis sp. Após o uso de thiabendazole houve melhora no quadro clínico e cura. Os autores chamam atenção para a importância de se estabelecer o diagnóstico diferencial entre Strongyloides e Rhabditis.

We report a case of parasitism by Rhabditis sp in a five-month-old child, from Goiás State, Brazil. He had a history of diarrhea with liquid and green faeces which later became bloody. Parasitological examination revealed the presence of larvae and adult female of Rhabditis sp. We used thiabendazole in this case after which the child improved. The authors suggest a better differential diagnostic between¹ Strongyloides and Rhabditis.

Avaliou-se a ação da ivermectina sobre larvas de quarto estádio em gatos infectados experimentalmente com Lagochilascaris minor. Foram utilizados 30 gatos (divididos, igualmente, em três grupos I, II e III), sendo que cada animal foi inoculado, por via oral, com 50 larvas de terceiro estádio do parasito. Cada animal, dos grupos I e II, foi tratado com ivermectina na dosagen de 200mig/kg, no quinto dia após o inóculo (DAI). Os animais do grupo I foram examinados, clinicamente, entre 30 e 40 dias e os do grupo II entre 180 e 190 dias sendo, em seguida, submetidos à necropsia. Os dez animais do grupo III, não foram tratados com a droga constituindo o grupo controle. Independentemente do período de observação, observou-se 100% de eficácia da droga, visto que houve total interrupção do ciclo biológico do parasito em todos animais tratados. Todos animais do grupo controle desenvolveram a infecção por Lagochilascaris minor.

In order to verify the action of ivermectin against fourth-stage larvae of Lagochilascaris minor, thirty cats were divided into three groups (I, II and III). Each animal was inoculated orally with 50 third-stage larvae. The cats from groups I and II were treated with Ivermectin (200/mug/kg/single dose/sc via) on fifth day after inoculation (DAI). Treatment evaluation was performed between 30 and 40 DAI (group I) and between 180 to 190 DAI (group II) using parasite macroscopic and microscopic research at autopsy. The 10 cats from group III were untreated (control group). The authors observed 100% drug efficacy, at all observation periods, by total interruption of parasite's biological cycle in each of the treated animals. All the control group developed Lagochilascaris minor infection.

A total of 25 specimens of Cavia porcellus (guinea pig), 5 Dasyprocta agouti (agouti), and 22 Calomys callosus (vesper mice) were inoculated with infective eggs of Lagochilascaris minor. The inoculum was prepared with embryonated eggs and orally administered to each individual animal through an esophagus probe. In parallel, 100 specimens of Felis catus domesticus were individually fed with 55-70 nodules containing 3rd-stage larvae encysted in tissues of infected rodents. Animals were examined and necropsied at different time intervals. The migration and encystment of L3 larva was observed in viscera, skeletal muscle, adipose and subcutaneous tissues from all rodents. Adult worms localized at abscesses in the cervical region, rhino, and oropharynx were recovered from domestic cats inoculated with infected rodent tissues. Through this study we can conclude that: (1) wild rodents act as intermediate hosts, characterizing this ascarid heteroxenic cycle; (2) in natural conditions rodents could possibly act as either intermediate hosts or paratenic hosts of Lagochilascaris minor; (3) despite the occurrence of an auto-infecting cycle, in prime-infection of felines (definite hosts) the cycle is only completed when intermediate hosts are provided; and (4) in the wild, rodents could serve as a source of infection for humans as they are frequently used as food in regions with the highest incidence of human lagochilascariasis.

Avaliação da eficácia terapêutica da Ivermectina sobre larvas de terceiro estádio de Lagochilascaris minor em camundongos infectados experimentalmente Avaliou-se a ação da ivermectina sobre larvas de 3o estádio, tanto em fase de migração, quanto larvas encistadas em tecidos de camundongos infectados experimentalmente com Lagochilascaris minor. Foram utilizados 120 camundongos (grupos I e II), sendo que cada animal foi inoculado, por via oral, com 1.000 ovos do parasito. Para verificar a ação da ivermectina sobre larvas em migração, o grupo I (60 animais) foi dividido igualmente em três subgrupos: I-A, I-B e I-C. No 7o dia após a inoculação (DAI), cada animal foi tratado com ivermectina na dosagem de 200 µg/Kg (subgrupo I-A) e 1.000 µg/Kg/dose única/via sc (subgrupo I-B). Com o objetivo de verificar a ação da droga sobre larvas encistadas, os animais do grupo II foram divididos igualmente em três subgrupos: II-A, II-B e II-C; no 45o DAI cada animal foi tratado com ivermectina na dosagem de 200 µg/Kg (subgrupo II-A) e 1.000 µg/Kg/dose única/via sc, (subgrupo II-B). Os animais dos subgrupos I-C e II-C constituíram o grupo controle. No 60o DAI todos os animais foram submetidos à pesquisa de larvas. Observou-se 99,5% de eficácia da droga na dosagem de 1.000 µg/Kg (grupo IB) sobre larvas de 3o estádio em fase de migração e eficácia inferior a 5% sobre larvas de 3o estádio encistadas, em ambas dosagens, bem como sobre larvas em migração na dosagem de 200 µg/Kg.

In this study we evaluated the potential action of ivermectin on third-stage larvae, both at migratory and encysted phases, in mouse tissues after experimental infection with Lagochilascaris minor. Study groups I and II consisted of 120 mice that were orally administered 1,000 parasite eggs. In order to assess ivermectin action upon migratory larvae, group I (60 mice) was equally split in three subgroups, namely I-A, I-B, and I-C. On the 7th day after inoculation (DAI), each animal from the subgroup I-A was treated with 200 µg/Kg ivermectin while subgroup I-B was given 1,000 µg/Kg, both groups received a single subcutaneous dose. To assess the drug action on encysted larvae, group II was equally split in three subgroups, namely II-A, II-B, II-C. On the 45th DAI each animal was treated with ivermectin at 200 µg/Kg (subgroup II-A) and 1,000 µg/Kg (group II-B) with a single subcutaneous dose. Untreated animals of subgroups I-C and II-C were used as controls. On the 60th DAI all animals were submitted to larva search. At a dose of 1,000 µg/Kg the drug had 99.5% effectiveness on third-stage migratory larvae (subgroup I-B). Ivermectin efficacy was lower than 5% on third-stage encysted larvae for both doses as well as for migratory larvae treated with 200µg/Kg.

Comparou-se o emprego de cortes em congelação de larvas de S. stercoralis e de S. ratti como fonte de antígenos na reação de imunofluorescência indireta (RIF) para o diagnóstico da estrongiloidíase humana. Os antígenos foram obtidos de coproculturas de fezes humanas e de ratos, respectivamente. Soros de 123 indivíduos foram analisados sendo 54 de pacientes com estrongiloidíase e 69 controles. Empregou-se conjugado anti IgG humano marcado com fluoresceína nos títulos ideais de 10 para S. stercoralis e 100 para S. ratti. A sensibilidade da RIF foi de 94,4% e 92,5% e a especificidade de 94,2% e 97,1% respectivamente para os antígenos de S. stercoralis e S. ratti. Para os 2 antígenos os títulos dos soros variaram de 20 a 2560. Houve correlação linear significativa (r = 0,85 p <FONT FACE="Symbol">£</font> 0,001) entre os títulos de anticorpos para os 2 antígenos. Concluiu-se que os 2 antígenos podem ser empregados na RIF. Diante da disponibilidade de obtenção de grande quantidade de antígeno em laboratório, economia do conjugado, por não haver diferença significativa entre sensibilidades e especificidades e haver correlação linear entre os títulos de anticorpos, a utilização do S. ratti é recomendada como antígeno no diagnóstico da estrongiloidíase humana

Cryo-microtome sections of larvae of Strongyloides stercoralis and S. ratti respectively obtained from human and rat feces cultures, were used as antigens. Fluoresceinate conjugates against human IgG were employed at the ideal titer of 10 for S. stercoralis and 100 for S. ratti. The sensitivity of the indirect immunofluorescence reaction (IIF) was 94.4% and 92.5% and the specificity 94.2% and 97.1% for the two specific larval antigens, respectively. Sera from 123 persons (54 from carriers of S. stercoralis infections and 69 from controls) were submitted to the reaction. The titers of different sera varied from 20 to 2560. There was a significant linear correlation (r = 0.85 p <FONT FACE="Symbol">£</font> 0.001) between the antibodies from the two species of larval antigens. We conclude that both antigens may be used in the IIF reaction for the diagnosis of human strongyloidiasis. Due to the feasibility of safe and low-cost mass production of S. ratti larvae in the laboratory with a considerable economy of conjugate, their utilization in the serum diagnosis of human strongyloidiasis is recommended

A partir de material colhido de lesões humanas estudou-se o ciclo evolutivo de Lagochilascaris minor empregando-se o modelo experimental: roedores (camundongos, hamster) e carnívoros (gatos, cão). Em camundongos inoculados com ovos infectantes, por via oral, observou-se eclosão de larvas de 3º estágio na parede do intestino, migração das mesmas para o fígado, pulmão, musculatura esquelética e tecido subcutâneo tornando-se em seguida encistadas. Em gatos alimentados com carcaças de camundongos infectados (60-235 dias de infecção) observou-se: eclosão de larvas de 3º estágio do interior dos nódulos (cistos) no estômago, migração através do esôfago, faringe, traquéia, e tecidos vizinhos (rino-orofaringe), linfonodos cervicais alcançando a fase adulta, em qualquer uma destas localizações, 9-20 dias pós inoculação. Não houve evolução do parasito até a fase adulta em gatos inoculados com ovos infectantes, por via oral, dado que reforça a necessidade do hospedeiro intermediário neste ciclo evolutivo. Em um dos gatos (alimentados com carcaças de camundongos infectados) necropsiado 43 dias pós inoculação, observou-se a ocorrência do ciclo auto-infectante de L. minor o que foi caracterizado pelo encontro de ovos em várias fases de evolução, larvas de 3º estágio e vermes adultos em tecidos do pulmão e região cervical. Acredita-se que algum componente do trato digestivo de carnívoros possa inviabilizar larvas de 3º estágio do interior de ovos L. minor, justificando a interrupção do ciclo evolutivo quando tais animais são inoculados com ovos infectantes. Ressalta-se o papel do hospedeiro intermediário nas primeiras fases do ciclo evolutivo deste helminto.

The life cycle of Lagochilascaris minor was studied using material collected from human lesion and applying the experimental model: rodents (mice, hamsters), and carnivorae (cats, dogs). In mice given infective eggs, orally, hatch of the third stage larvae was noted in the gut wall, with migration to liver, lungs, skeletal musculature and subcutaneous tissue becoming, soon after, encysted. In cats infected with skinned carcasses of mice (60 to 235 days of infection) it was observed: hatch of third stage larvae from the nodules (cysts) in the stomach, migration through the oesophagus, pharynx, trachea, related tissues (rhino-oropharynx), and cervical lymphonodes developing to the mature stage in any of these sites on days 9-20 post inoculation (P.I.). There was no parasite development up to the mature stage in cats inoculated orally with infective eggs, which indicates that the life cycle of this parasite includes an obligatory intermediate host. In one of the cats (fed carcass of infected mice) necropsied on day 43 P.I., it was observed the occurence of the self-infective cycle of L. minor in the lung tissues and in the cervical region which was characterized by the finding of eggs in different stages of development, third stage larvae and mature worms. It's believed that some component of the carnivorae gastrointestinal tracts may preclude the development of third stage larvae from L. minor eggs what explains the interruption of the life cycle in animals fed infective eggs. It's also pointed out the role of the intermediate host in the first stages of the life cycle of this helminth.

São relatados três casos de crianças com larva migrans visceral confirmados através do teste imunoenzimático ELISA, em Goiânia. Quadro pulmonar com infiltrado intersticial, tosse seca e eosinojilia sangüínea caracterizaram o primeiro caso. No segundo, os sinais clínicos presentes foram quadro respiratório com tosse seca, infiltrado pulmonar, além de eosinojilia sangüínea e hipergamaglobulinemia. Uma eosinofilia persistente, entre 1987-1989, sem qualquer outro sinal aparente, foi o que induziu à suspeita e confirmação, da parasitose no terceiro caso.

We report three cases of children with visceral larva migrans confirmed by enzyme-linked immu-nosorbent assay (ELISA), in Goiânia, Pulmonary interstitial infiltrates with dry cough and peripheral eosinophilia characterised the first case. Clinical and laboratorial finding in the second case included dry cougn, pulmonary infiltrates, peripheral eosinophilia and hypergammaglobulinaemia. A persistent eosino-philia, between 1987-1989, without apparent cause led to the confirmation of parasite infection in the third case.